Influenza resident survival guide: Difference between revisions
No edit summary |
|||
Line 1: | Line 1: | ||
{{CMG}}; {{AE}} {{MRV}} | {{CMG}}; {{AE}} {{MRV}} | ||
Line 14: | Line 14: | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{familytree | | | | | A01 | | A01=<div style="float: center; text-align: left; width: 35em; padding:1em;"> '''Characterize the symptoms:''' <br> | {{familytree | | | | | | | | | | A01 | | A01=<div style="float: center; text-align: left; width: 35em; padding:1em;"> '''Characterize the symptoms:''' <br> | ||
❑ [[Fever]] <br> | ❑ [[Fever]] <br> | ||
:❑ Abrupt onset <br> | :❑ Abrupt onset <br> | ||
Line 40: | Line 40: | ||
</div>}} | </div>}} | ||
{{familytree | | | | | |!| | |}} | {{familytree | | | | | | | | | | |!| | | ||}} | ||
{{familytree | | | | | B01 | | B01=<div style="float: left; text-align: left; width: 35em; padding:1em;"> '''Obtain a detailed history:''' <br> | {{familytree | | | | | | | | | | B01 | | B01=<div style="float: left; text-align: left; width: 35em; padding:1em;"> '''Obtain a detailed history:''' <br> | ||
❑ Age <br> | ❑ Age <br> | ||
❑ List of medications <br> | ❑ List of medications <br> | ||
Line 60: | Line 60: | ||
❑ Residents of nursing homes and other chronic-care facilities.<br> | ❑ Residents of nursing homes and other chronic-care facilities.<br> | ||
</div>}} | </div>}} | ||
{{familytree | {{familytree | | | | | | | | | | |!| | | | }} | ||
{{familytree | {{familytree | | | | | | | | | | C01 | | C01=<div style="float: left; text-align: left; width: 35em; padding:1em;">'''Examine the patient:''' <br> | ||
'''Appearance''' <br> | '''Appearance''' <br> | ||
Line 99: | Line 99: | ||
</div>}} | </div>}} | ||
{{Family tree/end}} | {{Family tree/end}}<br> <br> | ||
== | Shown below is an algorithm summarizing the [[diagnosis|diagnostic approach]] of [[Influenza]] according to the the Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza.<ref name="UyekiBernstein2019">{{cite journal|last1=Uyeki|first1=Timothy M|last2=Bernstein|first2=Henry H|last3=Bradley|first3=John S|last4=Englund|first4=Janet A|last5=File|first5=Thomas M|last6=Fry|first6=Alicia M|last7=Gravenstein|first7=Stefan|last8=Hayden|first8=Frederick G|last9=Harper|first9=Scott A|last10=Hirshon|first10=Jon Mark|last11=Ison|first11=Michael G|last12=Johnston|first12=B Lynn|last13=Knight|first13=Shandra L|last14=McGeer|first14=Allison|last15=Riley|first15=Laura E|last16=Wolfe|first16=Cameron R|last17=Alexander|first17=Paul E|last18=Pavia|first18=Andrew T|title=Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa|journal=Clinical Infectious Diseases|volume=68|issue=6|year=2019|pages=e1–e47|issn=1058-4838|doi=10.1093/cid/ciy866}}</ref> | ||
{{ | |||
{{familytree | | | | | | | | | | | {{Family tree/start}} | ||
{{familytree | | | | | {{familytree | | | | | | | | | F01 | | | | |F01=<div style="float: left; text-align: center; width: 20em; padding:1em;">Which Patients Should Be Tested for Influenza?</div>}} | ||
{{familytree | | | | {{familytree | | | | | |,|-|-|-|^|-|-|-|.| | | | | | }} | ||
{{familytree | |,|-|^|-|. | {{familytree | | | | | G01 | | | | | | G02 | | |G01=<div style="float: left; text-align: center; width: 10em; padding:1em;">During influenza activity</div>|G02=<div style="float: left; text-align: center; width: 10em; padding:1em;">During low influenza activity</div>}} | ||
{{familytree | D01 | | D02 | {{familytree | | | |,|-|^|-|.| | | |,|-|^|-|.| | }} | ||
{{familytree | {{familytree | | | D01 | | D02 | | D03 | | D04 |D01=Outpatients (including emergency department patients)|D02=Hospitalized Patients|D03=Outpatients|D04=Hospitalized Patients}} | ||
{{familytree | E01 | | E02 | {{familytree | | | |!| | | |!| | | |!| | | |!| | }} | ||
treatment decisions or <br> :❑ reduce use of unnecessary [[antibiotics]], <br> :❑ reduce further diagnostic testing, and :❑ reduce time in the emergency department, or :❑ influence [[antiviral]] treatment or [[chemoprophylaxis]] decisions for high-risk household contacts. < | {{familytree | | | E01 | | E02 | | E03 | | E04 | |E01=<div style="float: left; text-align: left; width: 20em; padding:1em;">❑ High-risk patients, including [[immunocompromised]] persons who present with [[influenza]]-like illness, [[pneumonia]], or nonspecific [[respiratory]] illness (eg, [[cough]] without [[fever]]) if the testing result will influence clinical management <br> ❑ patients who present with acute onset of [[respiratory]] symptoms with or without [[fever]], and either exacerbation of chronic medical conditions (eg, [[asthma]], [[chronic obstructive pulmonary disease]], [[heart failure]]) or known complications of [[influenza]] (eg, [[pneumonia]]) if the testing result will influence clinical management <br> ❑ Patients not at high risk for [[influenza]] complications who present with [[influenza]]-like illness, [[pneumonia]], or nonspecific [[respiratory]] illness (eg, [[cough]] without [[fever]]) and who are likely to be discharged home if the results might :❑ influence [[antiviral]] treatment decisions or <br> :❑ reduce use of unnecessary [[antibiotics]], <br> :❑ reduce further diagnostic testing, and <br> :❑ reduce time in the emergency department, or <br> :❑ influence [[antiviral]] treatment or [[chemoprophylaxis]] decisions for high-risk household contacts. </div> |E02=<div style="float: left; text-align: left; width: 20em; padding:1em;">❑ All patients requiring hospitalization with acute [[respiratory]] illness, including [[pneumonia]], with or without [[fever]] <br> ❑ All patients with acute worsening of chronic [[cardiopulmonary]] disease (eg, [[COPD]], [[asthma]], [[coronary artery disease]], or [[heart failure]]), as influenza can be associated with exacerbation of underlying conditions <br> ❑ All patients who are [[immunocompromised]] or at high risk of complications and present with acute onset of [[respiratory]] symptoms with or without [[fever]], as the manifestations of [[influenza]] in such patients are frequently less characteristic than in immunocompetent individuals <br> ❑ All patients who, while hospitalized, develop acute onset of [[respiratory]] symptoms, with or without [[fever]], or [[respiratory distress]], without a clear alternative diagnosis </div>|E03=<div style="float: left; text-align: left; width: 10em; padding:1em;">❑ Patients with acute onset of [[respiratory]] symptoms with or without [[fever]], especially for [[immunocompromised]] and high-risk patients </div>|E04=<div style="float: left; text-align: left; width: 10em; padding:1em;">❑ All patients requiring hospitalization with acute [[respiratory]] illness, with or without [[fever]], who have an epidemiological link to a person diagnosed with [[influenza]], an [[influenza]] outbreak or outbreak of acute [[febrile]] [[respiratory]] illness of uncertain cause, or who recently traveled from an area with known [[influenza]] activity. <br> ❑ Patients with acute, febrile [[respiratory tract illness]], especially children and adults who are [[immunocompromised]] or at high risk of complications, or if the results might influence [[antiviral treatment]] or [[chemoprophylaxis]] decisions for high-risk household contacts </div> }} | ||
of complications, or if the results might influence [[antiviral treatment]] or [[chemoprophylaxis]] decisions for high-risk household contacts < | |||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 19:58, 27 August 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mounika Reddy Vadiyala, M.B.B.S.[2]
Overview
Influenza, commonly known as the flu, is an infectious disease caused by the RNA virus called the influenza viruses A and B.
Causes
Common Causes
Complete Diagnostic Approach
Characterize the symptoms: ❑ Fever
❑ Myalgia Less common symptoms: | |||||||||||||||||||||||||||||||
Obtain a detailed history: ❑ Age Identify persons who are at high risk of complications from Influenza:
❑ Persons with immunosuppression, including that caused by medications or by HIV infection | |||||||||||||||||||||||||||||||
Examine the patient: Appearance Vital signs
Skin Eyes Nose Throat Lungs | |||||||||||||||||||||||||||||||
Shown below is an algorithm summarizing the diagnostic approach of Influenza according to the the Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza.[1]
Which Patients Should Be Tested for Influenza? | |||||||||||||||||||||||||||||||||||||||
During influenza activity | During low influenza activity | ||||||||||||||||||||||||||||||||||||||
Outpatients (including emergency department patients) | Hospitalized Patients | Outpatients | Hospitalized Patients | ||||||||||||||||||||||||||||||||||||
❑ High-risk patients, including immunocompromised persons who present with influenza-like illness, pneumonia, or nonspecific respiratory illness (eg, cough without fever) if the testing result will influence clinical management ❑ patients who present with acute onset of respiratory symptoms with or without fever, and either exacerbation of chronic medical conditions (eg, asthma, chronic obstructive pulmonary disease, heart failure) or known complications of influenza (eg, pneumonia) if the testing result will influence clinical management ❑ Patients not at high risk for influenza complications who present with influenza-like illness, pneumonia, or nonspecific respiratory illness (eg, cough without fever) and who are likely to be discharged home if the results might :❑ influence antiviral treatment decisions or :❑ reduce use of unnecessary antibiotics, :❑ reduce further diagnostic testing, and :❑ reduce time in the emergency department, or :❑ influence antiviral treatment or chemoprophylaxis decisions for high-risk household contacts. | ❑ All patients requiring hospitalization with acute respiratory illness, including pneumonia, with or without fever ❑ All patients with acute worsening of chronic cardiopulmonary disease (eg, COPD, asthma, coronary artery disease, or heart failure), as influenza can be associated with exacerbation of underlying conditions ❑ All patients who are immunocompromised or at high risk of complications and present with acute onset of respiratory symptoms with or without fever, as the manifestations of influenza in such patients are frequently less characteristic than in immunocompetent individuals ❑ All patients who, while hospitalized, develop acute onset of respiratory symptoms, with or without fever, or respiratory distress, without a clear alternative diagnosis | ❑ Patients with acute onset of respiratory symptoms with or without fever, especially for immunocompromised and high-risk patients | ❑ All patients requiring hospitalization with acute respiratory illness, with or without fever, who have an epidemiological link to a person diagnosed with influenza, an influenza outbreak or outbreak of acute febrile respiratory illness of uncertain cause, or who recently traveled from an area with known influenza activity. ❑ Patients with acute, febrile respiratory tract illness, especially children and adults who are immunocompromised or at high risk of complications, or if the results might influence antiviral treatment or chemoprophylaxis decisions for high-risk household contacts | ||||||||||||||||||||||||||||||||||||
Management
Symptomatic Relief
Symptom(s) | OTC Medicine |
---|---|
Fever, Aches, Pains, Sinus pressure, Sore throat | Analgesics |
Nasal congestion, Sinus pressure | Decongestants |
Sinus pressure, Runny nose, Watery eyes, Cough | Antihistamines |
Cough | Cough suppressant |
Sore throat | Local anesthetics |
Do's and Dont's
- Children and teenagers with flu symptoms (particularly fever) should avoid taking aspirin as taking aspirin in the presence of influenza infection (especially Influenzavirus B) can lead to Reye's syndrome, a rare but potentially fatal disease of the liver.[3]
References
- ↑ Uyeki, Timothy M; Bernstein, Henry H; Bradley, John S; Englund, Janet A; File, Thomas M; Fry, Alicia M; Gravenstein, Stefan; Hayden, Frederick G; Harper, Scott A; Hirshon, Jon Mark; Ison, Michael G; Johnston, B Lynn; Knight, Shandra L; McGeer, Allison; Riley, Laura E; Wolfe, Cameron R; Alexander, Paul E; Pavia, Andrew T (2019). "Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa". Clinical Infectious Diseases. 68 (6): e1–e47. doi:10.1093/cid/ciy866. ISSN 1058-4838.
- ↑ "Cold and Flu Guidelines: Influenza". American Lung Association. Retrieved 2007-09-16.
- ↑ Molotsky, Irvin (1986-02-15). "Consumer Saturday - Warning on Flu and Aspirin". New York Times. Retrieved 2007-05-25.